Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hitoshi Zembutsu

Showing results (51-60 of 79) with videos related to

Pageof 8
Sort By:
Journal of Human Genetics|August 22, 2009
Single nucleotide polymorphism in ABCG2 is associated with irinotecan-induced severe myelosuppressionPei-Chieng Cha, Taisei Mushiroda, Hitoshi Zembutsu, et al.
Clinical Chemistry|June 23, 2009
CYP2D6 genotyping for functional-gene dosage analysis by allele copy number detectionNaoya Hosono, Mamoru Kato, Kazuma Kiyotani, et al.
Pharmacogenetics and Genomics|February 2, 2012
A genome-wide association study identifies four genetic markers for hematological toxicities in cancer patients receiving gemcitabine therapyKazuma Kiyotani, Satoko Uno, Taisei Mushiroda, et al.
Oncology Letters|October 19, 2018
A prospective study to examine the accuracies and efficacies of prediction systems for response to neoadjuvant chemotherapy for muscle invasive bladder cancerYoichiro Kato, Hitoshi Zembutsu, Ryo Takata, et al.
Biological & Pharmaceutical Bulletin|July 31, 2022
Replication Study for the Association of Five SNPs Identified by GWAS and Trastuzumab-Induced Cardiotoxicity in Japanese and Singaporean CohortsChihiro Udagawa, Sherwin Kuah, Tatsunori Shimoi, et al.
Journal of Human Genetics|September 7, 2012
A genome-wide association study identifies a genetic variant in the SIAH2 locus associated with hormonal receptor-positive breast cancer in JapaneseSeham Elgazzar, Hitoshi Zembutsu, Atsushi Takahashi, et al.
Genes, Chromosomes & Cancer|January 31, 2003
Induction of tenascin-C by tumor-specific EWS-ETS fusion genesGoichi Watanabe, Hiroyuki Nishimori, Hideto Irifune, et al.
Oncogene|November 26, 2002
The Id2 gene is a novel target of transcriptional activation by EWS-ETS fusion proteins in Ewing family tumorsHiroyuki Nishimori, Yasushi Sasaki, Koichi Yoshida, et al.
Pharmacogenetics and Genomics|June 25, 2010
Lessons for pharmacogenomics studies: association study between CYP2D6 genotype and tamoxifen responseKazuma Kiyotani, Taisei Mushiroda, Naoya Hosono, et al.
Experimental and Therapeutic Medicine|September 21, 2012
Identification of a set of genes associated with response to interleukin-2 and interferon-α combination therapy for renal cell carcinoma through genome-wide gene expression profilingOsamu Mizumori, Hitoshi Zembutsu, Yoichiro Kato, et al.
Pageof 8

Showing results (51-60 of 79) with videos related to

Sort By:
Pageof 8
Journal of Human Genetics|August 22, 2009
Single nucleotide polymorphism in ABCG2 is associated with irinotecan-induced severe myelosuppressionPei-Chieng Cha, Taisei Mushiroda, Hitoshi Zembutsu, et al.
Clinical Chemistry|June 23, 2009
CYP2D6 genotyping for functional-gene dosage analysis by allele copy number detectionNaoya Hosono, Mamoru Kato, Kazuma Kiyotani, et al.
Pharmacogenetics and Genomics|February 2, 2012
A genome-wide association study identifies four genetic markers for hematological toxicities in cancer patients receiving gemcitabine therapyKazuma Kiyotani, Satoko Uno, Taisei Mushiroda, et al.
Oncology Letters|October 19, 2018
A prospective study to examine the accuracies and efficacies of prediction systems for response to neoadjuvant chemotherapy for muscle invasive bladder cancerYoichiro Kato, Hitoshi Zembutsu, Ryo Takata, et al.
Biological & Pharmaceutical Bulletin|July 31, 2022
Replication Study for the Association of Five SNPs Identified by GWAS and Trastuzumab-Induced Cardiotoxicity in Japanese and Singaporean CohortsChihiro Udagawa, Sherwin Kuah, Tatsunori Shimoi, et al.
Journal of Human Genetics|September 7, 2012
A genome-wide association study identifies a genetic variant in the SIAH2 locus associated with hormonal receptor-positive breast cancer in JapaneseSeham Elgazzar, Hitoshi Zembutsu, Atsushi Takahashi, et al.
Genes, Chromosomes & Cancer|January 31, 2003
Induction of tenascin-C by tumor-specific EWS-ETS fusion genesGoichi Watanabe, Hiroyuki Nishimori, Hideto Irifune, et al.
Oncogene|November 26, 2002
The Id2 gene is a novel target of transcriptional activation by EWS-ETS fusion proteins in Ewing family tumorsHiroyuki Nishimori, Yasushi Sasaki, Koichi Yoshida, et al.
Pharmacogenetics and Genomics|June 25, 2010
Lessons for pharmacogenomics studies: association study between CYP2D6 genotype and tamoxifen responseKazuma Kiyotani, Taisei Mushiroda, Naoya Hosono, et al.
Experimental and Therapeutic Medicine|September 21, 2012
Identification of a set of genes associated with response to interleukin-2 and interferon-α combination therapy for renal cell carcinoma through genome-wide gene expression profilingOsamu Mizumori, Hitoshi Zembutsu, Yoichiro Kato, et al.
Pageof 8